After a series of high-profile investigations in the pharmaceutical industry, Beijing is trying to reform its healthcare system and stamp out graft. The FT's Patti Waldmeir reports from Shanghai.


For more video content from the Financial Times, visit http://www.FT.com/video

Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes